Study Group: Centocor Remicade Prescribers: Rheumatoid Arthritis, Psoriatic Arthritis, Anklyosing Spondylitis, and Psoriasis (US)
Council Members in this Study Group: 77
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Avram GoldbergAssistant Professor
Albert Einstein College of Medicine
Avram Goldberg, MD, FACR, is Attending Physician at North Shore University Hospital and Assistant Professor at the Albert Einstein College of Medicine, New York. He is part of the Division of Rheumatology where he is responsible for treatment of autoimmune...
- Ara Dikranian
Partner and Rheumatologist
San Diego Arthritis Medical ClinicAra Dikranian, MD, is Partner and Rheumatologist at San Diego Arthritis Medical Clinic, a single-specialty private practice in San Diego, California. Dr. Dikranian is board certified in internal medicine and rheumatology. He completed his rheumatology...
Sunil DhawanClinical Assistant Professor of Dermatology
STANFORD UNIVERSITYSunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed...
- Brian Lester
Dermatologist
Brian W Lester, MDBrian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety...
- Dipti Doshi
Rheumatologist
HEALTHCARE PARTNERS MEDICAL GROUPDipti Doshi, MD, is a board certified Rheumatologist at Health Care Partners Medical group, California. Dr. Doshi is also board certified in Internal Medicine. Her special interests are in rheumatoid arthritis, lupus, pain-related to scleroderma, fibromyalgia,...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
November 19, 2009
Leo Pharma completes merger pact with Peplin | www.pharmabiz.com
The recent merger of Peplin with Leo pharma is of some significance and will benefit both companies. It would have been difficult for Peplin to fully develop and market their flagship product alone.
-
Presta Trial shows good results for Enbrel
October 14, 2009
New data from PRESTA trial demonstrate the benefit of Enbrel in patients with psoriasis & psoriatic arthritis | www.pharmabiz.com
This trial showed predicatably good results for Enbrel in patients with psoriasis and psoriatic arthritis. This included improvement in signs and symptoms and quality of life. This will increase sales of Enbrel in the short term. However the two newer agents, Humira and Stelara have better efficacy, and more convenient dosing regimens. Both will be doing similar studies.
-
Starpharma gets US patent for use of VivaGel for protection against STIs
September 29, 2009
Starpharma gets US patent for use of VivaGel for protection against STIs | www.pharmabiz.com
Starpharma's lead product, is a vaginal microbicide gel under development for the prevention of sexually transmitted infections (STIs), including genital herpes and HIV infection. The VivaGel® product concept is designed to offer a safe, convenient and affordable means for women to protect themselves from infection with genital herpes and HIV during sex. Surveys show that there is substantial demand in North America and Europe for such a product with an estimated billion dollar market for STI prevention products in the developed world.
-
Stelara new Option for Psoriasis
September 26, 2009
Stelara Approved to Treat Moderate to Severe Plaque Psoriasis in Adults | www.webmd.com
The FDA approved Stelara based on three studies of 2,266 patients who either got shots of Stelara or a placebo. Patients who got Stelara were more likely to achieve the studies' benchmark for reduction in psoriasis.In a news release, the FDA notes that because Stelara reduces the immune system's ability to fight infections, the product poses a risk of infection. "Serious infections have been reported in patients receiving the product and some of them have led to hospitalization. These infections were caused by viruses, fungi, or bacteria that have spread throughout the body. There may also be an increased risk of developing cancer," the FDA states.
-
Probiotics and Atopic Dermatitis
April 27, 2009
Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. | www.ncbi.nlm.nih.gov
Large, well-conducted meta-analysis shows as a preventative strategy, probiotics may have a modest effect on decreasing the incidence of atopic eczema. However, in terms of treating active disease or preventing recurrence of disease, no convincing evidence supports the use of the probiotics examined thus far.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Owner
- Physician - Division Head
- Physician - Director
- Director
- Partner
- President
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
January 25, 2008 | Boston
GLGi: Psoriasis and Medical DermatologyGLG Webcasts & Teleconferences
Leading Experts in Centocor Remicade Prescribers: Rheumatoid Arthritis, Psoriatic Arthritis, Anklyosing Spondylitis, and Psoriasis (US) have not participated in any GLG webcasts.